Two New Draft Guidance Documents Posted on HPUS website

The HPCUS Board has approved two draft documents to be posted for public comment. One addresses a topic for the first time by the HPUS: Drug Stability; the second is an extensive standard for the submission of technical information to the HPCUS. The Council on Pharmacy (CoP) has drafted a readm more…

Read More

HPUS Draft Revised Labeling Guidelines

The HPCUS Council on Pharmacy (CoP) has completed an extensive revision of the Labeling Guidelines Section of the HPUS. The draft Revised Labeled Guidelines includes detailed labeling information from the recently adopted Guidelines for Manufacturing Homeopathic Medicines. Labeling information from the FDA Compliance Policy Guide 400.400 (Conditions Under Which Homeopathic readm more…

Read More

New Monographs Added to HPUS

The Board of Directors of the Homeopathic Pharmacopeia Convention of the United States (HPCUS) is pleased to announce six new monographs have been added to the Homeopathic Pharmacopeia of the United States (HPUS). After extensive review and discussion by the Monograph Review and Pharmacopeia Revision Committees, the Board has approved readm more…

Read More

New Finalized Manufacturing Guidance in HPUS

The HPUS contains a newly approved set of Guidelines for Manufacturing Homeopathic Medicines that will affect every manufacturer and marketer of homeopathic drug products in the USA. All companies should familiarize themselves with these changes before the final implementation date to ensure a smooth and trouble free transition. The Guideline readm more…

Read More